[1]魏光杰,何佃菊.532nm绿激光格栅样光凝联合球内注药治疗糖尿病视网膜病变黄斑水肿[J].眼科新进展,2014,34(8):779-781.[doi:10.13389/j.cnki.rao.2014.0215]
　WEI Guang-Jie,HE Dian-Ju.532 run green grid laser photocoagulation combined with intravitreal Avastin injection for diabetic retinopathy macular edema[J].Recent Advances in Ophthalmology,2014,34(8):779-781.[doi:10.13389/j.cnki.rao.2014.0215]
点击复制

532nm绿激光格栅样光凝联合球内注药治疗糖尿病视网膜病变黄斑水肿
分享到：

《眼科新进展》[ISSN:1003-5141/CN:41-1105/R]

卷:
34卷
期数:
2014年8期
页码:
779-781
栏目:
应用研究
出版日期:
2014-08-05

文章信息/Info

Title:
532 run green grid laser photocoagulation combined with intravitreal Avastin injection for diabetic retinopathy macular edema
作者:
魏光杰; 何佃菊
山东省莱芜市，莱芜市人民医院眼科
Author(s):
WEI Guang-Jie; HE Dian-Ju
关键词:
糖尿病视网膜病变; 黄斑水肿; 格栅样光凝; Avastin
Keywords:
diabetic retinopathy;  macular edema;  grid laser photocoagulation;  Avastin
DOI:
10.13389/j.cnki.rao.2014.0215
文献标志码:
A
摘要:
目的　观察５３２ｎｍ绿激光格栅样光凝联合球内注药治疗糖尿病视网膜病变（ｄｉａｂｅｔｉｃｒｅｔｉｎｏｐａｔｈｙ，ＤＲ）黄斑水肿的临床疗效。方法　选择２０１１年１月至２０１２年１２月我院收治的ＤＲ黄斑水肿患者４０例（８０眼），随机分为治疗组和对照组，每组２０例，对照组给予单纯５３２ｎｍ绿激光格栅样光凝术，治疗组在５３２ｎｍ绿激光格栅样光凝术前给予球内注射Ａｖａｓｔｉｎ（美国Ｇｅｎｅｎｔｅｃｈ公司）。随访期末采用眼底镜及ＦＦＡ观察患者眼底改变情况，采用国际标准视力表检查患者治疗前后视力，同时使用光学相干断层扫描仪检查患者治疗前后的黄斑区视网膜厚度。结果　治疗组治愈２２眼，显效１６眼，无效２眼，总有效率为９５．０％；对照组治愈１７眼，显效１６眼，无效７眼，总有效率为８２．５％；经统计学分析，两组患者的总有效率差异有统计学意义（Ｐ＜０．０５），治疗组疗效好于对照组。治疗前视力比较，两组差异无统计学意义（Ｐ＞０．０５）；与治疗前视力相比，治疗后视力均显著提高（均为Ｐ＜０．０５）；治疗后视力组间比较，治疗组视力好于对照组（Ｐ＜０．０５）。治疗组和对照组治疗前黄斑区视网膜厚度分别为（４２５．４４±３８．２３）μｍ、（４３７．６６±３６．１２）μｍ，两组间差异无统计学意义（Ｐ＞０．０５）；治疗后黄斑区视网膜厚度分别为（１６５．２８±２５．６４）μｍ、（２７５．７８±４２．１４）μｍ，较治疗前均降低（均为Ｐ＜０．０５），且治疗组低于对照组（Ｐ＜０．０５）。结论　相对于单纯激光光凝术，５３２ｎｍ绿激光格栅样光凝联合球内注药治疗ＤＲ更加安全有效，术后视力恢复更快，黄斑水肿吸收更好。
Abstract:
Objective To discuss the clinical efficacy of 532 nm green grid laser photocoagulation combined with intravitreal Avastin injection for diabetic retinopathy ( DR) macular edema. Methods Forty patients ( 80 eyes) with DR macular edema in our hospital from January 2011 to December 2012 were chosen and divided into two groups ,20 cases in each group , the treatment group received the 532 nm green grid laser photocoagulation combined with intravitreal Avastin injection, and the control group with single 532 nm green grid laser photocoagulation , the postoperative fundus changes were observed by FFA and fundus photography , the visual acuity was checked, and the macular retinal thickness was detected by OCT. Results In the treatment group , the edema was cured in 22 eyes , effective in 16 eyes.ineffective in 2 eyes , the total effective rate was 95. 0% ;In the control group, the edema was cured in 17 eyes , effective in 16 eyes ,ineffective in 7 eyes , the total effective rate was 95. 0% ; Statistical difference was found between two groups (P < 0. 05 ) . There was no difference in preoperative visual acuity between two groups ( P > 0. 05 ) , the postoperative visual acuity in two groups all increased ( all P < 0. 05 ) .the experiment group was better than the control group (P <0. 05 ) . The preoperative macular retinal thickness of two groups were ( 425 . 44 + 38. 23 ) ym , ( 437. 66 + 36. 12 ) ym , which after operation were ( 165 . 28 + 25. 64 ) ym , ( 275. 78 + 42. 14 ) ym , statistical difference was found between two group rn postoperative macular retinal thickness ( P < 0. 05 ) . Conclusion Compared with the single 532 nm green grid laser photocoagulation , the 532 nm green grid laser photocoagulation combined with intravitreal Avastin injection for DR macular edema is more effective and safe with better postoperative visual acuity recovery.

相似文献/References:

[1]杜玮 刘子扬 周艳艳 雒雷鸣.糖尿病视网膜病变与血清胆红素水平的关系[J].眼科新进展,2012,32(5):000.
[2]范松涛 卢建民.阿司匹林与糖尿病患者玻璃体出血以及玻璃体切割术疗效的相关性研究[J].眼科新进展,2012,32(11):000.
[3]李艳 李筱荣 袁佳琴 潘斌.糖尿病大鼠视网膜中VEGF、PEDF的表达与血-视网膜屏障损伤[J].眼科新进展,2013,33(1):000.
[4]李朝晖 崔治华 胡晓英 孟丽珠 张敬维.糖尿病视网膜病变激光面积与疗效的分析[J].眼科新进展,2013,33(2):000.
[5]冯冬梅 朱鸿 施彩虹.CXC趋化因子及其受体在糖尿病视网膜病变中的作用[J].眼科新进展,2013,33(6):000.
[6]牛淑玲.糖尿病视网膜病变患者HbAlc、FPG与血小板参数的变化及危险因素分析[J].眼科新进展,2013,33(7):000.
[7]毕春潮 王睿 王建洲 雷春灵 董晓娟 王小莉 薛晓辉.Ad-PEDF对糖尿病视网膜病变大鼠视网膜新生血管的抑制作用[J].眼科新进展,2013,33(8):000.
[8]杨萍 孙书明 李晓鹏.辛伐他汀对糖尿病视网膜病变和炎症因子的影响[J].眼科新进展,2013,33(8):000.
[9]罗文婷 孙大卫.血管黏附蛋白-1在眼科疾病中的研究进展[J].眼科新进展,2013,33(8):000.
[10]李小璐 马雅玲.糖尿病视网膜病变大鼠视网膜VEGF和PEDF的动态表达[J].眼科新进展,2013,33(9):000.
[11]鲁丹 王康 王艳玲 林鹏耀 李茜 李明铭.后Tenon囊下注射曲安奈德辅助全视网膜光凝治疗糖尿病视网膜病变[J].眼科新进展,2013,33(5):000.
[12]陈素芳 曾莉 邵毅. 非诺贝特在糖尿病视网膜病变中的应用进展[J].眼科新进展,2014,34(3):283.
[13]朱岩,汪军,孟忻,等. 非增殖期糖尿病视网膜病变黄斑水肿对脉络膜横断面面积的影响[J].眼科新进展,2015,35(7):683.[doi:10.13389/j.cnki.rao.2015.0187]
　ZHU Yan,WANG Jun,MENG Xin,et al. Effects of macular edema on choroidal cross sec on area in non-proliferative diabetic retinopathy[J].Recent Advances in Ophthalmology,2015,35(8):683.[doi:10.13389/j.cnki.rao.2015.0187]
[14]洪婷婷,刘广峰,高新晓,等.糖尿病黄斑水肿玻璃体内注射康柏西普的短期疗效和椭圆体带完整性改变的观察[J].眼科新进展,2017,37(11):1053.[doi:10.13389/j.cnki.rao.2017.0266]
　HONG Ting-Ting,LIU Guang-Feng,GAO Xin-Xiao,et al.Short-term outcomes of intravitreal injection of conbercept for diabetic macular edema and restoration of ellipsoid zone[J].Recent Advances in Ophthalmology,2017,37(8):1053.[doi:10.13389/j.cnki.rao.2017.0266]
[15]徐静,唐晓娟,于健,等.糖尿病黄斑水肿患者病变程度与脉络膜厚度的关系[J].眼科新进展,2019,39(5):444.[doi:10.13389/j.cnki.rao.2019.0102]
　XU Jing,TANG Xiao-Juan,YU Jian,et al.Comparisons of choroidal thickness in relation to macular edema in type 2 diabetic patients[J].Recent Advances in Ophthalmology,2019,39(8):444.[doi:10.13389/j.cnki.rao.2019.0102]
[16]雷祥,范珂,崔红培,等.不同类型视网膜病变患者视网膜外层厚度变化研究[J].眼科新进展,2019,39(6):536.[doi:10.13389/j.cnki.rao.2019.0123]
　LEI Xiang,FAN Ke,CUI Hong-Pei,et al.Changes in outer retinal thickness in patients with different types of retinopathy[J].Recent Advances in Ophthalmology,2019,39(8):536.[doi:10.13389/j.cnki.rao.2019.0123]
[17]陈若瑜,曹丹,张良.糖尿病视网膜病变药物治疗研究进展[J].眼科新进展,2022,42(3):244.[doi:10.13389/j.cnki.rao.2022.0050]
　CHEN Ruoyu,CAO Dan,ZHANG Liang.Advances in drug therapy for diabetic retinopathy[J].Recent Advances in Ophthalmology,2022,42(8):244.[doi:10.13389/j.cnki.rao.2022.0050]
[18]郑雨薇,蒋正轩,李恒,等.2型糖尿病患者干眼相关指标分析[J].眼科新进展,2022,42(11):874.[doi:10.13389/j.cnki.rao.2022.0180]
　ZHENG Yuwei,JIANG Zhengxuan,LI Heng,et al.Analysis of dry eye related factors in type 2 diabetic patients[J].Recent Advances in Ophthalmology,2022,42(8):874.[doi:10.13389/j.cnki.rao.2022.0180]
[19]朱婷婷,黄丹,张春元,等.玻璃体内注射康柏西普对糖尿病黄斑水肿患者和继发于视网膜静脉阻塞的黄斑水肿患者的疗效差异[J].眼科新进展,2023,43(1):053.[doi:10.13389/j.cnki.rao.2023.0011]
　ZHU Tingting,HUANG Dan,ZHANG Chunyuan,et al.Different efficacies of intravitreal injection of conbercept for diabetic macular edema and macular edema secondary to retinal vein obstruction[J].Recent Advances in Ophthalmology,2023,43(8):053.[doi:10.13389/j.cnki.rao.2023.0011]

更新日期/Last Update: 2014-07-30